Northwestern Mutual Wealth Management Co. Cuts Stock Position in Danaher Corporation $DHR

Northwestern Mutual Wealth Management Co. cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 23.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,913 shares of the conglomerate’s stock after selling 12,187 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Danaher were worth $7,603,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Hilton Head Capital Partners LLC purchased a new position in Danaher in the 4th quarter worth approximately $27,000. Clal Insurance Enterprises Holdings Ltd raised its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher in the second quarter worth $25,000. Finally, Main Street Group LTD bought a new position in shares of Danaher during the first quarter worth $25,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Guggenheim cut their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. Finally, Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Price Performance

DHR stock opened at $210.07 on Thursday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a market capitalization of $147.68 billion, a P/E ratio of 37.31, a price-to-earnings-growth ratio of 2.58 and a beta of 0.78. The company has a fifty day simple moving average of $201.15 and a two-hundred day simple moving average of $192.19. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.